BofA/Merrill Lynch Downgrades Dr. Reddy's Laboratories (RDY) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Dr. Reddys Labs (RDY) Reports Q3 EPS of $0.40
February 14, 2013 6:54 AM ESTDr. Reddys Labs (NYSE: RDY) reported Q3 EPS of $0.40, versus $0.50 reported last year. Revenue for the quarter came in at $522 million, versus $505 million reported last year.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.... More
